CannaPharmaRx, Inc. (OTC:CPMD) is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the “endocannabinoid system” — one of the most widely expressed system of receptors in the human body.